Cilostazol

Product NDC
0615-7747
11-digit product format
006157747
Labeler code
0615
Product ID
0615-7747_84fd20f2-c938-45d9-8550-20c350d3f631
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cilostazol
Dosage form
TABLET
Route
ORAL
Labeler
NCS HealthCare of KY, Inc dba Vangard Labs
Application
ANDA077027
Marketing category
ANDA
Marketing start
2012-03-23
Marketing end
0000-00-00
Substance
CILOSTAZOL
Active strength
100 mg/1
Pharmacologic classes
Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0615-7747-392021-04-09C16284748780-19d75b9d0-2afd-f424-e053-dadaa90a57ce66e0ed7b-e29a-45ee-82bb-3db6142c2697
0615-7747-392020-01-31C16284748780-19d75b9d0-2afd-f424-e053-dadaa90a57ce66e0ed7b-e29a-45ee-82bb-3db6142c2697